Chimerix Inc

NASDAQ:CMRX   3:59:27 PM EDT
8.17
+0.16 (+2.00%)
Products

Chimerix Announces FDA Acceptance Of New Drug Application For Brincidofovir As A Medical Countermeasure For Smallpox

Published: 12/07/2020 12:26 GMT
Chimerix Inc (CMRX) - Chimerix Announces FDA Acceptance of New Drug Application for Brincidofovir As a Medical Countermeasure for Smallpox.
Chimerix Inc - FDA Granted Priority Review and Set Action Date of April 7, 2021 Under PDUFA.